| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 922.31M | 965.26M | 1.22B | 1.34B | 1.21B | 897.02M |
| Gross Profit | 17.88M | 9.72M | 15.65M | -27.55M | 67.78M | 52.86M |
| EBITDA | -13.31M | -26.76M | 2.60M | -12.75M | 74.43M | 30.91M |
| Net Income | -50.18M | -58.98M | -28.00M | -41.60M | 46.08M | -15.12M |
Balance Sheet | ||||||
| Total Assets | 388.47M | 401.44M | 454.24M | 478.32M | 484.95M | 476.82M |
| Cash, Cash Equivalents and Short-Term Investments | 32.52M | 35.47M | 30.01M | 36.46M | 50.61M | 47.67M |
| Total Debt | 119.69M | 114.67M | 105.46M | 87.27M | 63.65M | 108.23M |
| Total Liabilities | 166.07M | 176.38M | 174.68M | 170.23M | 139.74M | 180.58M |
| Stockholders Equity | 222.40M | 225.06M | 279.56M | 308.09M | 345.21M | 296.24M |
Cash Flow | ||||||
| Free Cash Flow | -10.01M | -14.59M | -7.51M | -31.70M | 10.44M | 65.10M |
| Operating Cash Flow | -6.08M | -3.52M | 22.02M | 6.05M | 26.82M | 71.68M |
| Investing Cash Flow | -13.45M | -13.47M | -33.03M | -37.66M | 27.12M | 23.32M |
| Financing Cash Flow | 14.18M | 7.72M | 6.96M | 19.01M | -40.00M | -66.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $1.09B | 22.42 | 8.89% | ― | -3.10% | -22.31% | |
66 Neutral | $1.16B | 25.87 | 3.67% | 3.33% | 5.35% | -1.43% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | $184.85M | -3.64 | -20.64% | ― | -8.00% | -35.86% | |
55 Neutral | $738.16M | -3.63 | -22.21% | ― | -12.07% | -821.68% | |
54 Neutral | $1.98B | -1,370.24 | -0.09% | 2.19% | -4.49% | -100.80% | |
48 Neutral | $482.19M | -10.60 | -9.27% | ― | 675.75% | 42.00% |
On November 24, 2025, Jeremy T. Bezdek resigned from the Board of Directors and all related committees at Alto Ingredients, Inc., effective immediately. His resignation was not due to any disagreements with the company regarding its operations, policies, or practices.
The most recent analyst rating on (ALTO) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Alto Ingredients stock, see the ALTO Stock Forecast page.